News & Events

——

Exhibition Report | Haibu Pharmaceutical Debuts at the 2024 6th CMC-China Expo

Classification:

Company News

Release time:

2024-08-19

On August 15-16, 2024, the 6th CMC-China Expo will be grandly held at the Suzhou International Expo Center!Haibu Pharmaceutical (Booth No.: C-H10-1) is one of the exhibiting companies at this event. This expo has gathered many leading domestic pharmaceutical companies, research institutions, and industry experts. The exhibition site is bustling with visitors, and all major thematic forums are fully seated with a lively atmosphere.

Exciting moments at the Haibu booth

This CMC exhibition has provided Haibu Pharmaceutical with a more direct and in-depth communication platform with many new and old clients. The Haibu booth was busy with people, and the atmosphere of communication was warm. We sincerely thank every friend who visited our booth; your trust and support are our inexhaustible motivation on the road ahead.

In the future, Haibu Pharmaceutical will remember the business philosophy of 'integrity, professionalism, cooperation, and win-win' and continuously enhance its R&D innovation capabilities. We will actively build a high-barrier technology platform with cost advantages and technical advantages to provide better quality products and services to our customers.

Beijing Haibu Pharmaceutical Technology Co., Ltd. (referred to as 'Haibu Pharmaceutical') was established in 2005 and is a high-tech enterprise focused on 'chemical drug R&D' as its core capability. It has a research center in Beijing, an API and formulation pilot validation center, and a GMP industrial production base.It mainly engages in API and formulation CRO services, MAH formulation R&D and licensing, API-related registration and commercial supply, innovative and improved drug R&D applications, etc., having been awarded the title of 'Top 20 Chinese Pharmaceutical R&D Companies' for several consecutive years. It has been recognized as a 'Beijing Science and Technology Research Development Institution', 'National High-tech Enterprise', 'Beijing Yizhuang Enterprise Innovation Center'.

Haibu Pharmaceutical has rich experience in the R&D transfer production, registration application of various dosage forms such as chemical APIs, oral solids, liquid formulations, sterile injections, external preparations, etc. The R&D products cover multiple therapeutic areas including anti-tumor, anti-depression, anti-epilepsy, anti-anxiety, cardiovascular & cerebrovascular diseases, digestive system disorders, respiratory system issues.

Heading to Europe | Haibu Pharmaceutical Shines at CPHI Milan 2024

【Exhibition】Looking back at the精彩, together we look forward to a new chapter! Haibu Pharmaceutical CPHI 2024 has successfully concluded!

Heading to Europe | Haibu Pharmaceutical Shines at CPHI Milan 2024

【Exhibition】Looking back at the精彩, together we look forward to a new chapter! Haibu Pharmaceutical CPHI 2024 has successfully concluded!

Beijing Hope Pharmaceutical Co., Ltd.

SEO

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.